Coherus And AbbVie Trade Legal Blows Amid Radical Adalimumab Price Offering

PBM SmithRx Works With Mark Cuban’s Firm To Offer Biosimilar At More Than 90% Off

 
• By Dean Rudge
  
Breach of contract
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products